• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃癌研究的进展将为控制这种癌症指明方向。

Advances in gastric cancer research will light the way to control this cancer.

作者信息

de Assumpção Paulo Pimentel, Burbano Rommel Rodrigues

机构信息

Universidade Federal do Pará, Núcleo de Pesquisas em Oncologia, Belém-Pará-Brasil 66075-110, Brazil.

Hospital Ophir Loyola, Laboratório de Biologia Molecula, Belém-Pará-Brasil 66063-240, Brazil.

出版信息

Chin J Cancer Res. 2022 Dec 30;34(6):575-578. doi: 10.21147/j.issn.1000-9604.2022.06.04.

DOI:10.21147/j.issn.1000-9604.2022.06.04
PMID:36714337
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9829496/
Abstract

Gastric adenocarcinoma (GC) is one of the most heterogeneous cancers, posing challenges to wide applications of the discoveries when compared to other cancers. Nevertheless, the benefits of research in the fight against GC are extraordinary, and even taking in mind the immense complexity of this disease, optimism is a great message to take home. Recent advances in GC research will pave the way for GC effective control, helping to save lives, together with permitting sustainable real-life support for those needing complex and high-expense interventions.

摘要

胃腺癌(GC)是最具异质性的癌症之一,与其他癌症相比,其研究成果的广泛应用面临挑战。然而,对抗GC的研究带来的益处是非凡的,即便考虑到这种疾病极其复杂,乐观仍是一个值得铭记的重要信息。GC研究的最新进展将为有效控制GC铺平道路,有助于挽救生命,同时也能为那些需要复杂且昂贵干预措施的患者提供可持续的实际支持。

相似文献

1
Advances in gastric cancer research will light the way to control this cancer.胃癌研究的进展将为控制这种癌症指明方向。
Chin J Cancer Res. 2022 Dec 30;34(6):575-578. doi: 10.21147/j.issn.1000-9604.2022.06.04.
2
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
3
Incidence of Hereditary Gastric Cancer May Be Much Higher than Reported.遗传性胃癌的发病率可能远高于报道的数字。
Cancers (Basel). 2022 Dec 12;14(24):6125. doi: 10.3390/cancers14246125.
4
Fluctuations of epigenetic regulations in human gastric Adenocarcinoma: How does it affect?人类胃腺癌中表观遗传调控的波动:它如何影响?
Biomed Pharmacother. 2019 Jan;109:144-156. doi: 10.1016/j.biopha.2018.10.094. Epub 2018 Nov 2.
5
Comparison and applicability of molecular classifications for gastric cancer.胃癌分子分型的比较与适用性。
Cancer Treat Rev. 2019 Jul;77:29-34. doi: 10.1016/j.ctrv.2019.05.005. Epub 2019 May 28.
6
Second Primary Cancers After Gastric Cancer, and Gastric Cancer as Second Primary Cancer.胃癌后的第二原发性癌症,以及作为第二原发性癌症的胃癌。
Clin Epidemiol. 2021 Jul 2;13:515-525. doi: 10.2147/CLEP.S304332. eCollection 2021.
7
A review of in vitro and in vivo models of oesophageal and gastric cancer.食管和胃癌的体外和体内模型综述。
Expert Opin Drug Discov. 2009 Dec;4(12):1267-79. doi: 10.1517/17460440903410203.
8
Proteomics in gastric cancer research: Benefits and challenges.胃癌研究中的蛋白质组学:优势与挑战。
Proteomics Clin Appl. 2009 Feb;3(2):185-96. doi: 10.1002/prca.200800151.
9
Gastric cancer genetic predisposition and clinical presentations: Established heritable causes and potential candidate genes.胃癌遗传易感性和临床表现:已确立的遗传性病因和潜在候选基因。
Eur J Med Genet. 2022 Jan;65(1):104401. doi: 10.1016/j.ejmg.2021.104401. Epub 2021 Dec 3.
10
Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.临床肿瘤进展 2011:美国临床肿瘤学会癌症进展年度报告。
J Clin Oncol. 2012 Jan 1;30(1):88-109. doi: 10.1200/JCO.2011.40.1919. Epub 2011 Dec 5.

引用本文的文献

1
THE MOLECULAR CANCER SUBTYPES VERSUS THE INDUSTRY ARSENAL. WHICH ONE DRIVES GASTRIC CANCER TREATMENT?分子癌症亚型与产业武器库。哪一个推动胃癌治疗?
Arq Bras Cir Dig. 2024 Jul 1;37:e1811. doi: 10.1590/0102-6720202400018e1811. eCollection 2024.
2
OLIGOMETASTASIS IN GASTRIC CANCER TREATMENT: IS THERE A PLACE FOR THE SURGEON?胃癌治疗中的寡转移:外科医生是否有一席之地?
Arq Bras Cir Dig. 2023 Sep 15;36:e1752. doi: 10.1590/0102-672020230034e1752. eCollection 2023.

本文引用的文献

1
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results.Claudin18.2 特异性 CAR T 细胞治疗胃肠道肿瘤的 1 期临床试验中期结果
Nat Med. 2022 Jun;28(6):1189-1198. doi: 10.1038/s41591-022-01800-8. Epub 2022 May 9.
2
The New Era of Immunotherapy in Gastric Cancer.胃癌免疫治疗的新时代
Cancers (Basel). 2022 Feb 18;14(4):1054. doi: 10.3390/cancers14041054.
3
PD-L1 Expression Associated with Epstein-Barr Virus Status and Patients' Survival in a Large Cohort of Gastric Cancer Patients in Northern Brazil.巴西北部一大群胃癌患者中PD-L1表达与爱泼斯坦-巴尔病毒状态及患者生存的相关性
Cancers (Basel). 2021 Jun 22;13(13):3107. doi: 10.3390/cancers13133107.
4
Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer.胃癌中微卫星不稳定性作为生物标志物价值的个体化患者数据汇总分析。
J Clin Oncol. 2019 Dec 10;37(35):3392-3400. doi: 10.1200/JCO.19.01124. Epub 2019 Sep 12.
5
Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas.癌症基因组图谱中 MYC 癌基因及其近端网络在多种癌症中的改变
Cell Syst. 2018 Mar 28;6(3):282-300.e2. doi: 10.1016/j.cels.2018.03.003.
6
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.错配修复缺陷可预测实体瘤对程序性死亡受体1(PD-1)阻断疗法的反应。
Science. 2017 Jul 28;357(6349):409-413. doi: 10.1126/science.aan6733. Epub 2017 Jun 8.
7
Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention.干细胞分裂、体细胞突变、癌症病因学与癌症预防。
Science. 2017 Mar 24;355(6331):1330-1334. doi: 10.1126/science.aaf9011.
8
Comprehensive molecular characterization of gastric adenocarcinoma.胃腺癌的全面分子特征分析。
Nature. 2014 Sep 11;513(7517):202-9. doi: 10.1038/nature13480. Epub 2014 Jul 23.